001     890467
005     20210623133424.0
024 7 _ |a 10.1016/j.msard.2021.102744
|2 doi
024 7 _ |a 2211-0348
|2 ISSN
024 7 _ |a 2211-0356
|2 ISSN
024 7 _ |a altmetric:97454472
|2 altmetric
024 7 _ |a 33517174
|2 pmid
024 7 _ |a WOS:000641391200027
|2 WOS
037 _ _ |a FZJ-2021-00980
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Filser, Melanie
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Mental symptoms in MS (MeSyMS): Development and validation of a new assessment
260 _ _ |a Amsterdam [u.a.]
|c 2021
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1613046726_4129
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Kein Post-print verfügbar!
520 _ _ |a BackgroundPatients with Multiple Sclerosis (MS) have an increased risk of suffering from mental and neuropsychiatric symptoms. So far, a fundamental problem in the clinical care of MS patients is that these symptoms are underdiagnosed and, as a consequence, often remain untreated. Present assessment tools have not been developed to be applied in patients with MS. This study aims to develop and validate a new questionnaire to identify disease-related mental symptoms in MS patients.MethodsA questionnaire has been developed by including the following subscales: social and emotional health problems, anxiety, and depression. To evaluate test quality and internal consistency, an item analysis has been conducted. After matching MS patients and control subjects on age and gender, we conducted group comparisons, a Receiver Operating Characteristic (ROC) Curve analysis and a binary logistic regression model.ResultsIn total, 314 MS patients and 100 matched control subjects were analysed. After performed item analysis, the questionnaire revealed an excellent internal consistency. Compared to control subjects, MS patients showed significant mental health problems in all three dimensions. In comparison to the subscales, the dimension of social and emotional health problems revealed the highest accuracy (AUC = 0.75; d = 0.948) and turned out to be the only scale that reliably differentiated between the groups.ConclusionsMeSyMS constitutes a valid screening instrument to detect mental symptoms in MS. Social and emotional health problems turned out to be the most important aspect when identifying disease-related mental health symptoms in MS.
536 _ _ |a 525 - Decoding Brain Organization and Dysfunction (POF4-525)
|0 G:(DE-HGF)POF4-525
|c POF4-525
|x 0
|f POF IV
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Baetge, Sharon Jean
|0 0000-0002-1166-5214
|b 1
700 1 _ |a Balloff, Carolin
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Buchner, Axel
|0 0000-0003-4529-3444
|b 3
700 1 _ |a Fink, Gereon Rudolf
|0 P:(DE-Juel1)131720
|b 4
|u fzj
700 1 _ |a Heibel, Markus
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Meier, Uwe
|b 6
700 1 _ |a Rau, Daniela
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Renner, Alina
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Schreiber, Herbert
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Ullrich, Sebastian
|0 0000-0002-1102-1080
|b 10
700 1 _ |a Penner, Iris-Katharina
|0 P:(DE-HGF)0
|b 11
|e Corresponding author
773 _ _ |a 10.1016/j.msard.2021.102744
|g Vol. 49, p. 102744 -
|0 PERI:(DE-600)2645330-7
|p 102744 -
|t Multiple Sclerosis and Related Disorders
|v 49
|y 2021
|x 2211-0348
856 4 _ |u https://juser.fz-juelich.de/record/890467/files/Filser_2021_Mult%20Scler%20Relat%20Dis_Mental%20symptoms%20in%20MS...-1.pdf
|y Restricted
909 C O |o oai:juser.fz-juelich.de:890467
|p VDB
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)131720
913 0 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-572
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-500
|4 G:(DE-HGF)POF
|v (Dys-)function and Plasticity
|x 0
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-08-25
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-08-25
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MULT SCLER RELAT DIS : 2018
|d 2020-08-25
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2020-08-25
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21